Salesforce (CRM) has been making significant moves, acquiring the AI marketing startup
Qualified in a $1.5 billion deal to boost their AI automation vision in service teams and enhance their Agentic Sales Engagement. It's also tightened its control over its data ecosystem, which could signify higher costs for CIOs. The addition of Agentforce to ChatGPT has earned Salesforce attention, and the consolidation with Novartis underpins the effective utilization of Agentforce within the healthcare sector. Furthermore, industry analysts have given positive outlooks, both Morgan Stanley and BTIG have maintained buy recommendations with respective PT of $300 and $335. However, despite this, several analysts have reduced their price targets, citing concerns about the company's future performance. Despite a recent share price slide, several voices in the industry highlight Salesforce's AI-driven push as reasons for optimism, notably Salesforce's performance in the AI Stock market and Tanvir Cowen still seeing upside in CRM."
Salesforce's emphasis seems to be focusing on its
AI sector with its 'Agentforce' Line and integration with ChatGPT. Many positive ratings from trusted sources underline the solid performance of the company, though caution is advised due to the recent share price drop.
Salesforce CRM News Analytics from Thu, 16 Oct 2025 07:00:00 GMT to Sat, 20 Dec 2025 22:18:45 GMT -
Rating 7
- Innovation 5
- Information 7
- Rumor 5
